Anhui Anke Biotechnology Co. Ltd. logo

Anhui Anke Biotechnology Co. Ltd. (300009)

Market Closed
13 Jun, 06:57
XSHE XSHE
¥
8. 95
-0.2
-2.19%
¥
14.95B Market Cap
- P/E Ratio
1% Div Yield
84,836,661 Volume
- Eps
¥ 9.15
Previous Close
Day Range
8.9 9.48
Year Range
7.38 11.55

Summary

300009 closed Friday lower at ¥8.95, a decrease of 2.19% from Thursday's close, completing a monthly increase of 8.48% or ¥0.7. Over the past 12 months, 300009 stock gained 3.11%.
300009 is not paying dividends to its shareholders.
The last earnings report, released on Apr 18, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.06%, based on the last three reports.
Anhui Anke Biotechnology Co. Ltd. has completed 2 stock splits, with the recent split occurring on May 14, 2021.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 300009 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

300009 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Anhui Anke Biotechnology Co. Ltd. Dividends

Anhui Anke Biotechnology Co. Ltd. logo
300009 3 weeks ago
Other
¥0.15 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 4 months ago
Other
¥0.1 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 27 May 2024
Other
¥0.25 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 19 May 2023
Other
¥0.25 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 13 May 2022
Other
¥0.2 Per Share

Anhui Anke Biotechnology Co. Ltd. Earnings

18 Apr 2025 Date
-
Cons. EPS
-
EPS
28 Mar 2025 Date
-
Cons. EPS
0.07
EPS
24 Oct 2024 Date
-
Cons. EPS
0.11
EPS
28 Aug 2024 Date
-
Cons. EPS
0.12
EPS
25 Apr 2024 Date
-
Cons. EPS
0.13
EPS
Anhui Anke Biotechnology Co. Ltd. logo
300009 3 weeks ago
Other
¥0.15 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 4 months ago
Other
¥0.1 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 27 May 2024
Other
¥0.25 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 19 May 2023
Other
¥0.25 Per Share
Anhui Anke Biotechnology Co. Ltd. logo
300009 13 May 2022
Other
¥0.2 Per Share
18 Apr 2025 Date
-
Cons. EPS
-
EPS
28 Mar 2025 Date
-
Cons. EPS
0.07
EPS
24 Oct 2024 Date
-
Cons. EPS
0.11
EPS
28 Aug 2024 Date
-
Cons. EPS
0.12
EPS
25 Apr 2024 Date
-
Cons. EPS
0.13
EPS

Anhui Anke Biotechnology Co. Ltd. (300009) FAQ

What is the stock price today?

The current price is ¥8.95.

On which exchange is it traded?

Anhui Anke Biotechnology Co. Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300009.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 14.95B.

Has Anhui Anke Biotechnology Co. Ltd. ever had a stock split?

Anhui Anke Biotechnology Co. Ltd. had 2 splits and the recent split was on May 14, 2021.

Anhui Anke Biotechnology Co. Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Lihua Song Ph.D. CEO
XSHE Exchange
CNE100000GY2 ISIN
CN Country
2,647 Employees
- Last Dividend
14 May 2021 Last Split
30 Oct 2009 IPO Date

Overview

Anhui Anke Biotechnology (Group) Co., Ltd., established in 2000 and headquartered in Hefei, China, specializes in the development, production, and international distribution of pharmaceutical products. The company focuses on a diverse range of therapeutic areas and biotechnological advancements, offering a wide spectrum of products from biopharmaceuticals to diagnostic kits and synthetic drugs. Anhui Anke Biotechnology is dedicated to leveraging its research and development capabilities to meet the evolving needs of the healthcare sector, both within China and globally.

Products and Services

  • Biopharmaceuticals:

    The company manufactures and markets biopharmaceuticals such as human growth hormone injections (branded as Ansomone), recombinant human interferon alpha 2b in various forms (branded as Anterferon), and monoclonal antibody drugs, including Trastuzumab for breast and gastric cancers, Bevacizumab for non-small cell lung cancer, and anti-PD1 for advanced cancers.

  • Diagnostic Kits:

    Anhui Anke offers a range of diagnostic kits targeting various medical needs, such as anti-sperm antibody, semen analysis tests, sperm life detection, sperm DNA fragmentation staining, leptin, and immunohistochemical diagnostics. Additionally, they provide autosomal and sex chromosome testing kits, paternity testing packages, and professional DNA testing services.

  • Synthetic Drugs:

    The company produces synthetic drugs in oral powders, dripping pills, and tablets and capsules form. These medicinal products cater to a broad spectrum of therapeutic categories.

  • Beauty and Personal Care Products:

    A range of beauty care products, including anti-aging treatments, masks, essential liquids, and mouthwash, are part of Anhui Anke's diversified portfolio, addressing the growing consumer demand for wellness and personal care items.

  • Topical Preparations and Ointments:

    Topical products such as adhesive plasters, oral solutions, and ointments complement the therapeutic offerings of the company, providing solutions for both prescription and over-the-counter needs.

  • Peptide APIs:

    Anhui Anke also specializes in the development and manufacturing of Peptide Active Pharmaceutical Ingredients (APIs), serving the pharmaceutical industry's need for high-quality, research-backed ingredients.

  • Tumor Biological Immunotherapy Products:

    This segment includes innovative treatments for cancer, utilizing biological responses and immunotherapy to combat tumor growth and spread, highlighting the company's commitment to advanced cancer treatment research.

Contact Information

Address: K-1, AnkeBio Building, Hefei, China, 230088
Phone: 86 551 6531 9890